Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
23
NVRO Quote, Financials, Valuation and Earnings
Last price:
$3.71
Seasonality move
:
-2.73%
Day range:
$3.52 - $4.00
52-week range:
$3.52 - $22.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.33x
P/B ratio:
0.52x
Volume:
762.8K
Avg. volume:
640.7K
1-year change:
-82%
Market cap:
$142M
Revenue:
$425.2M
EPS (TTM):
-$1.89
Nevro SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
NVRO
Nevro
|
11/01/2023 | 10-Q | 10-Q filing on 11/01/2023 | View Form |
|
NVRO
Nevro
|
08/01/2023 | 10-Q | 10-Q filing on 08/01/2023 | View Form |
|
NVRO
Nevro
|
04/26/2023 | 10-Q | 10-Q filing on 04/26/2023 | View Form |
|
NVRO
Nevro
|
11/02/2022 | 10-Q | 10-Q filing on 11/02/2022 | View Form |
|
NVRO
Nevro
|
08/03/2022 | 10-Q | 10-Q filing on 08/03/2022 | View Form |
|
NVRO
Nevro
|
05/04/2022 | 10-Q | 10-Q filing on 05/04/2022 | View Form |
|
NVRO
Nevro
|
11/08/2021 | 10-Q | 10-Q filing on 11/08/2021 | View Form |
|
NVRO
Nevro
|
08/04/2021 | 10-Q | 10-Q filing on 08/04/2021 | View Form |
|
NVRO
Nevro
|
05/05/2021 | 10-Q | 10-Q filing on 05/05/2021 | View Form |
|
NVRO
Nevro
|
11/05/2020 | 10-Q | 10-Q filing on 11/05/2020 | View Form |
|
NVRO
Nevro
|
08/05/2020 | 10-Q | 10-Q filing on 08/05/2020 | View Form |
|
NVRO
Nevro
|
05/05/2020 | 10-Q | 10-Q filing on 05/05/2020 | View Form |
|
NVRO
Nevro
|
02/25/2020 | 10-K | 10-K filing on 02/25/2020 | View Form |
|
NVRO
Nevro
|
11/06/2019 | 10-Q | 10-Q filing on 11/06/2019 | View Form |
|
NVRO
Nevro
|
08/08/2019 | 10-Q | 10-Q filing on 08/08/2019 | View Form |
|
NVRO
Nevro
|
05/09/2019 | 10-Q | 10-Q filing on 05/09/2019 | View Form |
|
NVRO
Nevro
|
02/21/2019 | 10-K | 10-K filing on 02/21/2019 | View Form |
|
NVRO
Nevro
|
11/05/2018 | 10-Q | 10-Q filing on 11/05/2018 | View Form |
|
NVRO
Nevro
|
08/02/2018 | 10-Q | 10-Q filing on 08/02/2018 | View Form |
|
NVRO
Nevro
|
05/07/2018 | 10-Q | 10-Q filing on 05/07/2018 | View Form |
|
NVRO
Nevro
|
02/22/2018 | 10-K | 10-K filing on 02/22/2018 | View Form |
|
NVRO
Nevro
|
11/06/2017 | 10-Q | 10-Q filing on 11/06/2017 | View Form |
|
NVRO
Nevro
|
08/07/2017 | 10-Q | 10-Q filing on 08/07/2017 | View Form |
|
NVRO
Nevro
|
05/08/2017 | 10-Q | 10-Q filing on 05/08/2017 | View Form |
|
NVRO
Nevro
|
02/23/2017 | 10-K | 10-K filing on 02/23/2017 | View Form |
|
NVRO
Nevro
|
11/07/2016 | 10-Q | 10-Q filing on 11/07/2016 | View Form |
|
NVRO
Nevro
|
08/08/2016 | 10-Q | 10-Q filing on 08/08/2016 | View Form |
|
NVRO
Nevro
|
05/09/2016 | 10-Q | 10-Q filing on 05/09/2016 | View Form |
|
NVRO
Nevro
|
02/29/2016 | 10-K | 10-K filing on 02/29/2016 | View Form |
|
NVRO
Nevro
|
11/09/2015 | 10-Q | 10-Q filing on 11/09/2015 | View Form |
|
NVRO
Nevro
|
08/06/2015 | 10-Q | 10-Q filing on 08/06/2015 | View Form |
|
NVRO
Nevro
|
05/29/2015 | 10-K | 10-K filing on 05/29/2015 | View Form |
|
NVRO
Nevro
|
05/11/2015 | 10-Q | 10-Q filing on 05/11/2015 | View Form |
|
NVRO
Nevro
|
03/18/2015 | 10-K | 10-K filing on 03/18/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 0.73% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.55% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.65% over the past day.
